A Study of NHL907 in Healthy Adult Participants

Phase 1 Recruiting 64 enrolled NeuHyll AUS Pty Ltd NeuHyll Therapeutics Inc · collab

RandomizedSequentialTriple-blindTreatment

Summary

The goal of this study is to evaluate the safety, tolerability and pharmacokinetics of NHL907 when administered as multiple oral doses in healthy adult participants.

Timeline

Start: 2026-05-12
Primary completion: 2027-02
Completion: 2027-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	NHL907	Unknown	—	Oral

Indications

No indication recorded.